Skip to content
value.today

Link Medicine Corp

Total raised
$60 M
2 rounds on record
Latest round
$20 M
Apr 2010
First round on record
Sep 2008
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Link Medicine Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2010$20 MNo. 2$10 to $50 million

Link Medicine Corp: Raise no. 2, Apr 2010

Investors in this round

9 investors had bought by the notice of Apr 30, 2010: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John F. Dee · Executive Officer, Director
  • Michael E. Fitzgerald · Executive Officer
  • Michael E. Solomon · Executive Officer
  • Peter T. Lansbury · Executive Officer
  • R. Michael Poole · Executive Officer
  • David E. Guyer · Director
  • David Michael Frankel · Director
  • Edward E. Scolnick · Director
  • Michael E. Ross · Director
  • Nick E. Galakatos · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael E. Fitzgerald, Chief Financial Officer and Treasurer. Source: SEC Form D, newest notice filed Apr 30, 2010. Read the notice at the SEC.

equitySEC
Sep 2008$40 MNo. 1$10 to $50 million

Link Medicine Corp: Raise no. 1, Sep 2008

Investors in this round

4 investors had bought by the notice of Sep 29, 2008: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $40 M offered
Smallest investment taken
$300,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$750,000
Finders' fees
none
Paid to its own people
$450,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in De

People named in the notice

  • Adam J. Rosenberg · Executive Officer, Director
  • David Neafus · Executive Officer
  • Peter T. Lansbury · Executive Officer, Director
  • Scott Young · Executive Officer
  • David Guyer · Director
  • Edward Scolnick · Director
  • Michael Ross · Director
  • Nick Galakatos · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • MTS Securities, LLC (CRD 104059) · broker-dealer MTS Securities, MTS (CRD 104059) · New York, NySold in no state named

Remarks in the notice

  • On fees: “$375,000 of this amount has been paid, and the remaining amount will be paid upon the occurrence of certain conditions, but no later than March 31, 2009.”

Signed by David Neafus, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 29, 2008. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Link Medicine Corp chose not to state its revenue in its newest notice of a funding round (Apr 2010).

    SEC Form D · Apr 2010

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2010

That is all the official record says: Link Medicine Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Link Medicine Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Link Medicine Corp
NameRoleNamed in
John F. DeeExecutive officerApr 2010
Michael E. FitzgeraldExecutive officerApr 2010
Michael E. SolomonExecutive officerApr 2010
Peter T. LansburyExecutive officerApr 2010
R. Michael PooleExecutive officerApr 2010
Adam J. RosenbergExecutive officerSep 2008
David NeafusExecutive officerSep 2008
Scott YoungExecutive officerSep 2008
David E. GuyerDirectorApr 2010
David Michael FrankelDirectorApr 2010
Edward E. ScolnickDirectorApr 2010
John F. DeeDirectorApr 2010
Michael E. RossDirectorApr 2010
Nick E. GalakatosDirectorApr 2010
Adam J. RosenbergDirectorSep 2008
David GuyerDirectorSep 2008
Edward ScolnickDirectorSep 2008
Michael RossDirectorSep 2008
Nick GalakatosDirectorSep 2008
Peter T. LansburyDirectorSep 2008